Improving memory support for patients with mild cognitive impairment
Improving Memory for Treatment for Patients Experiencing Mild Cognitive Impairment: Are Constructive or Non-constructive Memory Supports More Helpful?
This study is testing different types of memory support to see which ones help older adults with mild cognitive impairment remember treatment information better than those without MCI.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | University of California, Berkeley Academic / other |
| Locations | 1 site (Berkeley, California) |
| Trial ID | NCT05668481 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of different types of memory support for individuals experiencing mild cognitive impairment (MCI) compared to those without MCI. It aims to determine how these supports can enhance memory for treatment content and adherence to therapy. Participants aged 60 and older will be recruited, and their memory recall will be assessed alongside their sleep and circadian functioning. The study will compare constructive and non-constructive memory supports to identify which is more beneficial for each group.
Who should consider this trial
Good fit: Ideal candidates are individuals aged 60 and older who are experiencing mild cognitive impairment and have difficulties with sleep and circadian functioning.
Not a fit: Patients with active and progressive mental or physical illnesses or those unable to participate in assessments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment adherence and outcomes for patients with mild cognitive impairment.
How similar studies have performed: While the approach of using memory support in treatment for MCI is innovative, similar studies have shown promise in enhancing treatment outcomes through cognitive support strategies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Participants 60 years and older will be recruited. 2. Fluent in English. 3. Experiencing some difficulties relating to sleep and circadian functioning and (d) a score of 19-25 on the Montreal Cognitive Assessment (for the MCI group) and score 26-30 on the Montreal Cognitive Assessment (for the non-MCI group) (e) Have a computer to use and an internet connection and (f) be able to attend sessions weekly and on the same day each week. Exclusion criteria: 1. Presence of an active and progressive mental or physical illness or neurological degenerative disease; 2. Night shift work \>2 nights per week in the past 3 months; 3. Not able and willing to participate in and/or complete the assessments and participate in the treatment.
Where this trial is running
Berkeley, California
- University of California, Berkeley — Berkeley, California, United States (Recruiting)
Study contacts
- Study coordinator: Allison G Harvey, PhD
- Email: aharvey@berkeley.edu
- Phone: 5106427138
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.